Literature DB >> 19868739

EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : XII. THE EFFECTS OF SUBCUTANEOUS INJECTIONS OF VACCINES OF BACTERIUM PNEUMOSINTES IN MAN.

P K Olitsky1, F L Gates.   

Abstract

Thirteen volunteers were injected subcutaneously with a vaccine prepared from two strains of Bacterium pneumosintes. Three doses were given corresponding, by opacity tests, to 1,000, 2,000, and 2,000 million staphylococci. The intervals between the several injections were 5 and 8 days. Local reactions of mild and transitory character only were noted. Constitutional reactions, also mild and transitory, consisting of headache, depression, and generalized muscular pains, were infrequently observed. None of the men was prevented by the vaccine from pursuing his ordinary duties. The vaccinations induce a transitory leucocytosis and lead to the appearance of specific agglutinins in the blood serum.

Entities:  

Year:  1923        PMID: 19868739      PMCID: PMC2128376          DOI: 10.1084/jem.37.4.471

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  A METHOD OF STANDARDIZING BACTERIAL SUSPENSIONS.

Authors:  F L Gates
Journal:  J Exp Med       Date:  1920-01-01       Impact factor: 14.307

2.  A REPORT ON ANTIMENINGITIS VACCINATION AND OBSERVATIONS ON AGGLUTININS IN THE BLOOD OF CHRONIC MENINGOCOCCUS CARRIERS.

Authors:  F L Gates
Journal:  J Exp Med       Date:  1918-10-01       Impact factor: 14.307

3.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : V. BACTERIUM PNEUMOSINTES AND CONCURRENT INFECTIONS.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1921-06-30       Impact factor: 14.307

4.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : XI. ANTIBODIES IN THE BLOOD AFTER RECOVERY FROM EPIDEMIC INFLUENZA.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1923-02-28       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.